Enzyme Immunoassay Market Future Trends Influencing Growth Through 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Enzyme Immunoassay Market In 2026 And 2030?

The enzyme immunoassay market size has experienced robust growth in recent years. It is projected to increase from $21.5 billion in 2025 to $23.09 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.4%. The expansion observed in the historic period was largely due to the limited availability of automated eia systems, a reliance on manual microplate readers, the growing clinical laboratory infrastructure, the increasing prevalence of chronic and infectious diseases, and the adoption of conventional reagents and kits.

The enzyme immunoassay market is anticipated to undergo significant expansion in the coming years, with its size projected to reach $30.37 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.1%. This expected growth throughout the forecast period stems from the advancement of fully automated EIA analyzers, the expansion of personalized medicine and precision diagnostics, the increasing integration of laboratory information systems, the rising adoption of software and data analysis tools, and a growing demand from academic and research institutions. Prominent trends identified for this period include the increased uptake of automated EIA analyzers, a surge in therapeutic drug monitoring applications, the broader utilization of multiplex testing and high-throughput assays, an expansion in oncology and infectious disease testing, and a heightened emphasis on laboratory data integration and workflow efficiency.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25763&type=smp

Which Key Drivers Are Affecting The Enzyme Immunoassay Market Development?

The increasing prevalence of infectious diseases is expected to propel the expansion of the enzyme immunoassay market going forward. Infectious diseases are defined as illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread from person to person. The challenge of infectious diseases is escalating as antimicrobial resistance makes it progressively difficult to treat common infections, leading to prolonged illness, higher medical costs, and increased mortality. Enzyme immunoassays are highly valuable in the diagnosis of infectious diseases, as they allow for the sensitive and specific detection of antigens or antibodies in patient samples, enabling early identification, effective monitoring, and timely treatment of infections such as HIV, hepatitis, and influenza. For instance, in April 2025, according to the Minnesota Department of Health, a US-based government agency, the share of HIV cases among males aged 35 to 39 rose from 10% in 2023 to 17% in 2024, indicating a notable increase in this age group’s proportion of total cases. Consequently, the expanding burden of infectious diseases is driving the growth of the enzyme immunoassay market.

What Are The Main Segments Within The Enzyme Immunoassay Market Segment Structure?

The enzyme immunoassay market covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End-Use: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, Other End-Uses

Subsegments:

1) By Reagents And Kits: Antibodies, Antigens, Substrates, Buffers And Stabilizers

2) By Analyzers Or Instruments: Fully Automated EIA Analyzers, Semi-Automated EIA Systems, Microplate Readers, Washers And Incubators

3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information System Integration Tools, Instrument Calibration And Validation Services, Technical Support And User Training

What Trends Are Transforming The Enzyme Immunoassay Market?

Leading companies in the enzyme immunoassay market are concentrating on introducing innovative enzyme immunoassay (EIA) solutions, such as fully automated enzyme immunoassays, aiming to enhance diagnostic accuracy, minimize manual errors, and improve workflow efficiency in clinical laboratories. Fully automated enzyme immunoassays are defined as diagnostic systems that execute the entire testing process autonomously, thereby boosting speed, precision, and consistency in laboratory outcomes. For instance, in July 2024, Fujirebio Holdings Inc., a Japan-based in vitro diagnostics (IVD) company, launched the fully automated Lumipulse G GFAP assay exclusively for research use only (RUO), thereby expanding its neuro-biomarker portfolio. This particular RUO chemiluminescent enzyme immunoassay is designed to measure glial fibrillary acidic protein (GFAP) in human plasma and serum using the LUMIPULSE G platform, delivering results in a mere 35 minutes. It serves as an astrocytic biomarker linked to conditions such as multiple sclerosis, Alzheimer’s and Parkinson’s diseases, stroke, and traumatic brain injury. This assay further strengthens Fujirebio’s expanding neuro menu, which currently features NfL, pTau217, and sTREM2, enabling comprehensive neurodegenerative disease profiling on a single automated system.

Who Are The Companies Participating In The Enzyme Immunoassay Market?

Major companies operating in the enzyme immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company (BD), PerkinElmer Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Diasorin S.p.A., Bio-Techne Corporation, Quidel Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Helena Laboratories Corporation, Cayman Chemical Company, Enzo Life Sciences Inc., RayBiotech Inc., MyBioSource Inc., Boster Biological Technology, Hycult Biotech, Calbiotech Inc.

Get The Full Enzyme Immunoassay Market Report:

https://www.thebusinessresearchcompany.com/report/enzyme-immunoassay-global-market-report

Which Region Leads The Enzyme Immunoassay Market In Terms Of Market Share?

North America was the largest region in the enzyme immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enzyme immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Enzyme Immunoassay Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=25763&type=smp

Browse Through More Reports Similar to the Global Enzyme Immunoassay Market 2026, By The Business Research Company

Enteral Feeding Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-feeding-devices-global-market-report

Enteral Feeding Formula Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-feeding-formula-global-market-report

Enteral Nutrition Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-nutrition-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795